#10: Novel anticoagulants in AF: An overview of the latest data with Dr Robert McBane
The past year has brought an embarrassment of riches in the realm of anticoagulation for patients with atrial fibrillation, as dabigatran, rivaroxaban, and apixaban vie to compete with warfarin.
CONCLUSION: In hypertensive and diabetic patients, higher OPG values were associated with impaired LA function assessed by 2D-STE. In this high-risk patient group, serum OPG can be used as a risk predictor for LA mechanical dysfunction. PMID: 32462219 [PubMed - as supplied by publisher]
Philips Wins Regulatory Nod for Clinical Surveillance Biosensor Philips won a nod from FDA and a CE mark for a next-generation wireless wearable biosensor to help monitor COVID-19 patients in hospital. The Amsterdam, Netherlands-based company touts its next-generation device as being able to enhance clinical surveillance in its patient deterioration detection solution to help clinicians detect risk so they can intervene earlier and help improve care in lower acuity care areas. Â Eko Moves Deeper into Telemedicine in the Age of Social Distancing The digital health company is launching a platform that will combin...
Publication date: June 2020Source: IJC Heart &Vasculature, Volume 28Author(s): Timothy Shih, Karina Ledezma, Mark McCauley, Jalees Rehman, William L. Galanter, Dawood Darbar
Conditions: Leukemia, Chronic Lymphatic; Mantle Cell Lymphoma Intervention: Sponsor: European Georges Pompidou Hospital Recruiting
Review the various types of antiarrhythmic agents used in the treatment of atrial fibrillation in this primer. How should the selection of an appropriate drug be made?U.S. Pharmacist
The most common form of sustained cardiac arrhythmia, which is characterized by irregular heartbeats, is atrial fibrillation (AF). The maintenance of AF is mediated by changes in the atrial structural and electrical properties.1 AF is a major risk factor for ischemic stroke and heart failure,2,3 which are associated with enhanced morbidity, mortality, and socioeconomic burden.4 The prevalence of AF is estimated to markedly increase as the population ages. Therefore, it is important to elucidate the molecular mechanisms underlying AF.
Atrial fibrillation (AF) is the most common postoperative arrhythmia and can cause increased length of stay, costs, morbidity, and mortality. Little information exists about postoperative AF after major head and neck surgery, but it is thought to occur more frequently than after surgery at other extra-thoracic sites. A retrospective cohort study was implemented, including patients who had undergone major head and neck surgery and who had follow-up records covering a minimum of 60 days postoperative.
LEFT atrial appendage (LAA) thrombus formation is a well-known complication of both atrial fibrillation and mitral stenosis, with a high potential for morbidity and mortality.1 Several factors may play a role in why this is the case but, ultimately, decreased LAA contractility results in a low- flow state.1 Prevention in those with atrial fibrillation often is managed medically with rhythm control via antiarrhythmics and oral anticoagulation, or it can be treated with procedures such as percutaneous arrythmia ablation, Direct Current Cardioversion (DCCV), LAA occlusion device placement, and LAA ligation.
ConclusionLA substrate modification in addition to PVI using LGE ‐MRI‐guided CBA is feasible but still experimental. The efficacy and safety have to be investigated in a prospective randomized trial.